Abiopharma

News list

📋 HOWARD HORN (Officer) plans to sell 5K shares of ULTRAGENYX PHARMACEUTICAL INC. (at $24.92 each, total $117K) Filed: Aug 03, 2026 | ID: 007510

Full text

News bot Aug. 3, 2026, 8:19 p.m.
📋 Form 144 Filing: HOWARD HORN

Company: ULTRAGENYX PHARMACEUTICAL INC.

Filing Date: 2026-08-03

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 4,696
- Price per Share: $24.92
- Total Value: $117,024.32
- Planned Sale Date: 2026-08-03
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36276
- Issuer Contact Phone: (415) 483-8800
- Issuer Address: 60 Leveroni Court, Novato, CA, 94949
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 98489224.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock and performance shares during the period of 3/1/2025 through 3/1/2026.